Founder, DEKA Research and Development Corporation
Founder and Co-Chair, Dept. of Bioengineering, Stanford University
Founder and CEO, Esperion Therapeutics
Chairman, CEO, & Founder, Alexandria Real Estate Equities
Co-Founder, Hunch and Founder Collective
Chairman and CEO, Accelerator
Biologist, Fred Hutchinson Cancer Research Center
|
|
A smattering of fundraising announcements involving Boston-area companies and investors, along with a student entrepreneurship program in this collection of local news tidbits:
—Skyword, a Boston-based marketing company that links freelance copywriters with advertisers and other clients, has raised... Read more »
I was pretty slow about getting around to reading Thinking, Fast and Slow. The career-capping book by Princeton psychologist Daniel Kahneman, one of the founders of behavioral economics, spent months on all the bestseller lists back in 2011. I finally... Read more »
All eyes in the biotech world will soon turn to the American Society of Clinical Oncology’s annual meeting in Chicago, but for now, the industry keeps humming along. This week’s news was highlighted by partnerships, product launches and big name hirings—and... Read more »
The Boston area’s best-known startup hub is taking another big step in its national expansion plans.
The Cambridge Innovation Center, an all-in-one office space and services provider that houses some 500 companies near the MIT campus, is opening a branch... Read more »
Ninepoint Medical earned the distinction of becoming the first—and to date, the only—medical device maker seeded by startup creation specialist Third Rock Ventures when it set up shop in 2009. Some four years and $33 million later, Ninepoint’s vision, a product... Read more »
First of all, the company is no longer called the Daily Grommet. Now it’s just The Grommet.
“We still execute daily,” says CEO Jules Pieri, “but we dropped the word because it seemed to be superfluous.” She adds, “We love... Read more »
[Corrected on 5/16/13, 9:11 a.m., see below] Fresh off raising $265 million to bankroll its ninth fund, Atlas Venture has forged strategic partnerships with Amgen and Novartis to help supply the bigger companies with innovative new drug candidates. The... Read more »
Just a little over a month to go before our fifth annual flagship conference, XSITE 2013 (Xconomy Summit on Innovation, Technology, & Entrepreneurship) at Babson College. The date is June 19, the theme is “Boston’s Tech Revival,” and the agenda is... Read more »
Updated 10 a.m. with new item
Some news on VC fundraising, startup investment, corporate layoffs, and student entrepreneurship in this midweek rundown of items to catch up on:
—Matrix Partners, based in Waltham, MA, has confirmed that it’s... Read more »
A prominent leader in the tech-startup community is moving on.
Walt Doyle, the longtime CEO of Where, which was acquired by PayPal in April 2011, has left the company as of today. Doyle served as general manager of PayPal Media... Read more »
There’s some more fuel for the online database arms race today: Boston-based Cloudant has secured a new $12 million investment round.
The money will bankroll Cloudant’s general growth, which includes a new office in San Francisco, complementing Cloudant’s previous footprint in Boston,... Read more »
A couple of years back, business software company LogMeIn bought a little startup called Pachube. This happens all the time, of course—a public company snapping up a small fry, hoping to bring some scrappier DNA or a promising product into... Read more »
Yesterday, we ran the first part of a wide-ranging interview with Henri Termeer, the legendary biotech entrepreneur and former CEO of Cambridge, MA-based Genzyme. He spoke about what kinds of startups he likes to get involved in, the trend toward... Read more »
For Radius Health, it’s all about September.
That’s when the Cambridge, MA-based biotech will unveil the mid-stage data on a version of its experimental osteoporosis drug, BAO58, which is administered through a patch affixed to the skin.
CEO Michael Wyzga makes... Read more »
It’s time to catch up with Dyn. You know, the once-bootstrapped tech dynamo from Manchester, NH, which raised a big venture round last fall and has been making some acquisitions as of late.
Today the Web infrastructure company said it... Read more »
Henri Termeer could have easily faded away into obscurity a couple years ago. The biotech pioneer could have relaxed at his oceanside home in Maine, played a little golf. Or, if he wanted, he could have made loads of money at... Read more »
In the rush to revolutionize taxicabs, the hot new property isn’t a fancy black sedan or a network of hustling cabbies. Instead, digital entrepreneurs are suddenly racing toward the 21st century version of hitchhiking.
So-called “ridesharing” services, which enlist everyday... Read more »
It was a busy week of big promise and big moves for biotechs on the East Coast. One biotech added to a string of partnerships and awaits results from a key mid-stage study for one of its own drugs. Another signed... Read more »
Not every speech is improved by visual aids. Abraham Lincoln made do without PowerPoint at Gettysburg (though wags have tried to reimagine that), and Franklin Roosevelt’s voice on the radio in 1933 calmed a nation rattled by the Great Depression... Read more »
Visiting Scholar, MIT
Research Fellow, MIT Sloan School and Entrepreneurship Center
Founding Director, Massachusetts Technology Transfer Center
Instructor in Pediatrics, Harvard Medical School
Founder and Managing Partner, PureTech Ventures
Managing Dir. of Life Sciences, Hercules Technology Growth Capital
Partner, North Bridge Venture Partners
Chairman and CEO, Nanobiosym Diagnostics Inc.
Managing Director, CommonAngels
Professor, MIT Sloan School of Management
San Francisco · 6/3/13
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
